Panuveitis in patient on ipilimumab/nivolumab combination for small-cell lung cancer treated with an intravitreal dexamethasone implant.

L Hefler, Jade; M Bailey, Lauren; El Rahi, Cynthia; C Schefler, Amy; Bernicker, Eric H

L Hefler, Jade; M Bailey, Lauren; El Rahi, Cynthia; C Schefler, Amy; Bernicker, Eric H.

L Hefler J; Department of Pharmacy, The University of Kansas Health System, Kansas, USA.
M Bailey L; Department of Pharmacy, Harris Health System, Houston, TX, USA.
El Rahi C; Department of Pharmacy, Houston Methodist Hospital, Houston, TX, USA.
C Schefler A; Department of Pharmacy, Houston Methodist Hospital, Houston, TX, USA.
Bernicker EH; Department of Pharmacy, Houston Methodist Hospital, Houston, TX, USA.

J Oncol Pharm Pract ; 27(5): 1261-1264, 2021 Jul.

Article en En | MEDLINE | ID: mdl-33108990

Asunto(s)

Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos; Dexametasona/uso terapéutico; Panuveítis/inducido químicamente; Anciano; Femenino; Humanos; Inmunoterapia; Ipilimumab/efectos adversos; Neoplasias Pulmonares/tratamiento farmacológico; Recurrencia Local de Neoplasia; Nivolumab/efectos adversos; Panuveítis/tratamiento farmacológico; Carcinoma Pulmonar de Células Pequeñas/tratamiento farmacológico

Palabras clave

Immunotherapy; checkpoint inhibitor; immune-related adverse event; panuveitis

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Panuveítis Límite: Aged / Female / Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google